NO20006047L - Fremgangsmåte for genterapi - Google Patents

Fremgangsmåte for genterapi

Info

Publication number
NO20006047L
NO20006047L NO20006047A NO20006047A NO20006047L NO 20006047 L NO20006047 L NO 20006047L NO 20006047 A NO20006047 A NO 20006047A NO 20006047 A NO20006047 A NO 20006047A NO 20006047 L NO20006047 L NO 20006047L
Authority
NO
Norway
Prior art keywords
procedures
gene therapy
therapy
gene
Prior art date
Application number
NO20006047A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006047D0 (no
Inventor
Martin Braddock
Callum Jeffrey Campbell
Jean-Luc Schwachtgen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20006047D0 publication Critical patent/NO20006047D0/no
Publication of NO20006047L publication Critical patent/NO20006047L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20006047A 1998-06-02 2000-11-29 Fremgangsmåte for genterapi NO20006047L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method

Publications (2)

Publication Number Publication Date
NO20006047D0 NO20006047D0 (no) 2000-11-29
NO20006047L true NO20006047L (no) 2001-02-01

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006047A NO20006047L (no) 1998-06-02 2000-11-29 Fremgangsmåte for genterapi

Country Status (28)

Country Link
US (1) US6689758B1 (de)
EP (2) EP1083934B1 (de)
JP (1) JP2002516676A (de)
KR (1) KR20010043968A (de)
CN (1) CN1311822A (de)
AP (1) AP2000001999A0 (de)
AT (1) ATE246518T1 (de)
AU (1) AU770497B2 (de)
BR (1) BR9910877A (de)
CA (1) CA2334171A1 (de)
DE (1) DE69910202T2 (de)
DK (1) DK1083934T3 (de)
EA (1) EA200001124A1 (de)
EE (1) EE200000790A (de)
ES (1) ES2205830T3 (de)
HR (1) HRP20000832A2 (de)
HU (1) HUP0103252A3 (de)
ID (1) ID27483A (de)
IL (1) IL139936A0 (de)
IS (1) IS5742A (de)
NO (1) NO20006047L (de)
NZ (1) NZ508505A (de)
PL (1) PL345207A1 (de)
PT (1) PT1083934E (de)
SK (1) SK18322000A3 (de)
TR (2) TR200100348T2 (de)
WO (1) WO1999062561A2 (de)
YU (1) YU75600A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
EP1467207B1 (de) * 2002-01-10 2008-06-04 Takeda Pharmaceutical Company Limited Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
AU2003302337A1 (en) * 2002-12-31 2004-07-29 The Johns Hopkins University Wound healing method and kits
EP1671655A4 (de) * 2003-08-29 2009-08-12 Anges Mg Inc Gentherapie für hauterkrankungen mit nadelfreier spritze
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
HRP20150759T1 (hr) 2007-05-11 2015-08-14 Adynxx, Inc. Ekspresija gena i bolovi
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
CN104487096B (zh) 2012-05-10 2020-09-15 埃迪恩克斯股份有限公司 用于活性成分递送的配制物
CA2957250A1 (en) 2014-08-15 2016-02-18 Adynxx, Inc. Oligonucleotide decoys for the treatment of pain
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763209A (en) 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
AUPN855496A0 (en) 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
CA2334171A1 (en) 1999-12-09
ES2205830T3 (es) 2004-05-01
HUP0103252A2 (hu) 2001-12-28
EP1083934A2 (de) 2001-03-21
AU770497B2 (en) 2004-02-26
ID27483A (id) 2001-04-12
PT1083934E (pt) 2003-12-31
IL139936A0 (en) 2002-02-10
EP1281763A3 (de) 2003-07-09
BR9910877A (pt) 2002-01-22
EP1083934B1 (de) 2003-08-06
WO1999062561A3 (en) 2000-08-03
JP2002516676A (ja) 2002-06-11
WO1999062561A2 (en) 1999-12-09
NZ508505A (en) 2003-04-29
EA200001124A1 (ru) 2001-08-27
CN1311822A (zh) 2001-09-05
TR200102985T2 (tr) 2002-06-21
HRP20000832A2 (en) 2001-04-30
EP1281763A2 (de) 2003-02-05
YU75600A (sh) 2004-03-12
NO20006047D0 (no) 2000-11-29
DK1083934T3 (da) 2003-12-01
DE69910202D1 (de) 2003-09-11
HK1034465A1 (en) 2001-10-26
AU4156099A (en) 1999-12-20
KR20010043968A (ko) 2001-05-25
PL345207A1 (en) 2001-12-03
ATE246518T1 (de) 2003-08-15
IS5742A (is) 2000-11-28
DE69910202T2 (de) 2004-06-17
EE200000790A (et) 2002-04-15
HUP0103252A3 (en) 2003-09-29
US6689758B1 (en) 2004-02-10
AP2000001999A0 (en) 2000-12-31
SK18322000A3 (sk) 2001-11-06
TR200100348T2 (tr) 2001-07-23

Similar Documents

Publication Publication Date Title
ID27841A (id) Turunan-turunan biaril terapeutik
DK1637127T3 (da) Terapeutisk mikroskum
DE69826421D1 (de) Bildgesteuerte Eingriffsverfahren
NO20001870L (no) Ny fremgangsmÕte for behandling
NO20004688D0 (no) Terapi ved østrogenassosierte lidelser
DE69933079D1 (de) Katheter
DE69921764D1 (de) Katheter
NO20005179D0 (no) Medikament behandling
NO20006047L (no) Fremgangsmåte for genterapi
DE69912327D1 (de) Katheter
DK0967286T3 (da) Leucinaminopeptodase-gen
GB0025890D0 (en) Gene therapy
GB9900009D0 (en) Gene therapy
EP1077258A4 (de) Menschliches HRPI-Gen
NO20012301D0 (no) Ny fremgangsmåte for behandling
GB0406539D0 (en) Gene therapy
ATA203199A (de) Ablauf
NO994148D0 (no) Fremgangsmåte for sekvensering
SE9803069D0 (sv) New gene
SE9803148D0 (sv) New gene
SE9802023D0 (sv) New therapeutic use
IT1299788B1 (it) Stumento irrigatore-aspiratore per chirurgia videolaparoscopica
KR970016254U (ko) 물리치료용 찜질주머니
GB9910587D0 (en) Gene therapy
GB9920837D0 (en) Gene therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application